Ramakrishnan, a distinguished structural biologist and Nobel Laureate in Chemistry (2009), is renowned for his groundbreaking ...
Yonsei University, Zymedi, and Evotec Awarded US$ 4.5 Million Grant for Novel Lung Disease Therapies
Evotec, Yonsei University, and Zymedi have been awarded a US$ 4.5 million grant from the Korea Institute of Advanced Technology (KIAT) to develop fir ...
Evotec, Yonsei University, and Zymedi have been awarded a US$ 4.5 million grant from the Korea Institute of Advanced Technology (KIAT) to develop first-in-class biologic therapies for lung diseases, ...
Macquarie University researchers have worked with an international team of scientists to achieve a major milestone in ...
The completion of chromosome synXVI allows scientists to explore new possibilities in metabolic engineering and strain ...
Scientists have completed construction of the final chromosome in the worlds' first synthetic yeast genome following more than a decade of work, opening new possibilities for creating resilient, ...
Macquarie University researchers have worked with an international team of scientists to achieve a major milestone in ...
Evotec SE, together with Yonsei University and the Korean biotech company Zymedi, will receive a $4.5 million grant from the ...
Yonsei University, Zymedi and Evotec receive US$ 4.5m grant from the Korea Institute of Advanced Technology under the Korean Ministry for Trade, Industry and EnergyFunding supports a novel collaborati ...
An Oxford company which uses AI to develop cancer treatments has achieved further validation for its approach to tackling multiple tumours. Oxford Drug Design's colorectal cancer model study on mice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback